VRTX34:BVMF
Vertex Pharmaceuticals Inc BDR
R$79.36
0.00%
(0.00) 1D
Oct 19, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX34...
Open
R$79.00
High
R$79.36
Low
R$79.00
Mkt. cap
127.22B
Avg. vol.
297.00
Volume
1.89K
52-wk high
R$89.01
52-wk low
R$65.18
Shares outstanding
253.46M
No. of employees
6K
Open
R$79.00
High
R$79.36
Low
R$79.00
Mkt. cap
127.22B
Avg. vol.
297.00
Volume
1.89K
52-wk high
R$89.01
52-wk low
R$65.18
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
Vertex Pharmaceuticals (VRTX) Reports ALYFTREK Child Data, Is The Stock Still Undervalued?
Yahoo Finance
·
2 days ago
Vertex (VRTX) Stock May Be 35% Undervalued Despite New ALYFTREK Data
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc BDR
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com